Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 5/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10603334 | 0.85 | NPC1 (0.58) | TDP1ATML3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL28752433 | 0.81 | ESR1 (0.55) | ESR1ESR2TDP1L3MBTL1ALDH1A1 | |
| SCHEMBL27653587 | 0.81 | TDP1 (0.41) | ESR1ESR2TDP1ATML3MBTL1 | |
| SCHEMBL28752431 | 0.81 | ESR1 (0.59) | ESR1ESR2TDP1L3MBTL1ALDH1A1 | |
| SCHEMBL4902023 | 0.81 | TDP1 (0.50) | TDP1ATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL11804658 | 0.79 | ATM (0.49) | TDP1ATML3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL1131746 | 0.78 | ESR1 (0.49) | ESR1ESR2ALDH1A1CYP3A4LMNA | |
| SCHEMBL28194375 | 0.78 | ESR1 (0.49) | ESR1ESR2TDP1L3MBTL1ALDH1A1 | |
| SCHEMBL8387012 | 0.78 | ATM (0.47) | TDP1ATML3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL20483494 | 0.78 | ESR1 (0.79) | ESR1ESR2TDP1L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1791901-B1 | STABILIZATION OF ORGANIC MATERIALS | BASF SE (DE) | 2018-03-28 | — | — | EP | disclosed |
| US-9051448-B2 | Stabilization of organic materials | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| US-9051448-B2 | Stabilization of organic materials | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| US-9051448-B2 | Stabilization of organic materials | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| US-20080269382-A1 | Stabilization of Organic Materials | BASF SE (DE) | 2008-10-30 | — | — | US | disclosed |
| US-20080269382-A1 | Stabilization of Organic Materials | BASF SE (DE) | 2008-10-30 | — | — | US | disclosed |
| US-20080269382-A1 | Stabilization of Organic Materials | BASF SE (DE) | 2008-10-30 | — | — | US | disclosed |
| EP-1791901-A2 | STABILIZATION OF ORGANIC MATERIALS | Ciba SC Holding AG (CH) | 2007-06-06 | — | — | EP | disclosed |
| WO-2006024611-A2 | STABILIZATION OF ORGANIC MATERIALS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269382-A1 | Stabilization of Organic Materials | LPO, PPOX, HMOX1 | ESR1 2631/4885ESR2 3457/4885TDP1 723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.